SFI
BDSI

Susquehanna Fundamental Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-139,641
Closed -$504K – 1883
2021
Q3 		$504K Buy
139,641
+126,273
+945% +$476K 0.01% 1206
2021
Q2 		$48K Buy
+13,368
New +$47.2K ﹤0.01% 1625

Other funds holding BDSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna Fundamental Investments's BDSI Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 139,641 shares — an estimated $504K sold.

Susquehanna Fundamental Investments first reported a position in BDSI in Q2 2021 and held it in 2 quarters. The position peaked at $504K in Q3 2021. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 139,641 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $504K.
  • Susquehanna Fundamental Investments first reported a position in BioDelivery Sciences International, Inc. in Q2 2021 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's BioDelivery Sciences International, Inc. position peaked at $504K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.